» Articles » PMID: 29795293

Profiling Human Breast Epithelial Cells Using Single Cell RNA Sequencing Identifies Cell Diversity

Abstract

Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to subsequent loss of tissue homeostasis. Several distinct epithelial subpopulations have been proposed, but complete understanding of the spectrum of heterogeneity and differentiation hierarchy in the human breast remains elusive. Here, we use single-cell mRNA sequencing (scRNAseq) to profile the transcriptomes of 25,790 primary human breast epithelial cells isolated from reduction mammoplasties of seven individuals. Unbiased clustering analysis reveals the existence of three distinct epithelial cell populations, one basal and two luminal cell types, which we identify as secretory L1- and hormone-responsive L2-type cells. Pseudotemporal reconstruction of differentiation trajectories produces one continuous lineage hierarchy that closely connects the basal lineage to the two differentiated luminal branches. Our comprehensive cell atlas provides insights into the cellular blueprint of the human breast epithelium and will form the foundation to understand how the system goes awry during breast cancer.

Citing Articles

Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling.

Regner M, Garcia-Recio S, Thennavan A, Wisniewska K, Mendez-Giraldez R, Felsheim B Cell Genom. 2025; 5(2):100765.

PMID: 39914387 PMC: 11872555. DOI: 10.1016/j.xgen.2025.100765.


RANK/RANKL Signaling Pathway in Breast Development and Cancer.

Perez-Chacon G, Santamaria P, Redondo-Pedraza J, Gonzalez-Suarez E Adv Exp Med Biol. 2025; 1464():309-345.

PMID: 39821032 DOI: 10.1007/978-3-031-70875-6_16.


Classification of Breast Cancer Through the Perspective of Cell Identity Models.

Iggo R, MacGrogan G Adv Exp Med Biol. 2025; 1464():185-207.

PMID: 39821027 DOI: 10.1007/978-3-031-70875-6_11.


ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER breast cancer.

Liang J, Yao X, Aouad P, Wang B, Crocker L, Chaudhuri S Nat Cancer. 2025; 6(2):357-371.

PMID: 39805955 DOI: 10.1038/s43018-024-00898-8.


Advancements in the Application of scRNA-Seq in Breast Research: A Review.

Zhang Z, Ma X, La Y, Guo X, Chu M, Bao P Int J Mol Sci. 2025; 25(24.

PMID: 39769466 PMC: 11677372. DOI: 10.3390/ijms252413706.


References
1.
Lehmann B, Bauer J, Chen X, Sanders M, Chakravarthy A, Shyr Y . Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011; 121(7):2750-67. PMC: 3127435. DOI: 10.1172/JCI45014. View

2.
Robin Y, Penel N, Perot G, Neuville A, Velasco V, Ranchere-Vince D . Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors. Mod Pathol. 2012; 26(4):502-10. DOI: 10.1038/modpathol.2012.192. View

3.
Morel A, Ginestier C, Pommier R, Cabaud O, Ruiz E, Wicinski J . A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nat Med. 2017; 23(5):568-578. DOI: 10.1038/nm.4323. View

4.
Choudhury S, Almendro V, Merino V, Wu Z, Maruyama R, Su Y . Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 2013; 13(1):117-30. PMC: 3703476. DOI: 10.1016/j.stem.2013.05.004. View

5.
Li B, Dewey C . RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12:323. PMC: 3163565. DOI: 10.1186/1471-2105-12-323. View